Tag: ICH

Rapid ich

Rapid ICH receives new US FDA clearance with “highest sensitivity and...

RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...

NICO raises US$12.5 million in oversubscribed investment round

NICO Corporation has completed a US$12.5 million capital raise in an oversubscribed round that will scale the business, and leverage continued progress on the company's recently completed adaptive...

IRRAS announces educational webinar series alongside Jacobs Institute and University of...

IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...

NICO announces completed enrolment in trial evaluating new ICH intervention approach

NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...
Rapid ich

RapidAI receives US FDA clearance for Rapid Hyperdensity

RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...

Stroke in young people may be associated with increased likelihood of...

The risk of being diagnosed with a new cancer in the follow-up of patients with a first-ever stroke is particularly increased in patients younger...
attention evt basilar

ATTENTION results indicate “we have finally conquered the basilar artery” with...

This year’s European Stroke Organisation Conference (ESOC 2022; 4–6 May, Lyon, France) saw results from ATTENTION—a multicentre randomised controlled trial (RCT) evaluating the benefit...